ClinicalTrials.Veeva

Menu
C

Coastal Pediatric Research | Summerville, SC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Rocatinlimab
AMG 451
PF-07321332
JNJ-53718678

Parent organization

This site is a part of Coastal Pediatric Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 15 total trials

A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASTRO)

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent subje...

Active, not recruiting
Atopic Dermatitis
Drug: Rocatinlimab
Drug: Placebo

The purpose of this study is to learn about the safety, tolerability and immune effects of a pneumococcal vaccine in toddlers.Participants will take...

Enrolling
Pneumococcal Disease
Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)
Biological: PG4

The purpose of this study is to learn about the safety and immune effects of a new pneumococcal vaccine in infants. The immune response is how the bo...

Enrolling
Pneumococcal Disease
Biological: PG4
Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)

The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called varian...

Enrolling
COVID-19
SARS-CoV-2 Virus
Biological: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose

The purpose of this study is to evaluate the growth and development outcomes of infants fed a new infant formula and toddler drink through 24 months...

Active, not recruiting
Growth
Other: Human Milk
Other: Human Milk Toddler Drink

This study evaluates an investigational vaccine that is designed to protect humans against infection with respiratory syncytial virus (RSV) and is ad...

Enrolling
Respiratory Syncytial Virus (RSV)
Biological: Investigational RSV vaccine MV-012-968 (Dosage 3; single-dose)
Other: Placebo (two-dose)

The objective of the study is to evaluate the safety and tolerability of 4 injections of VAX-24 (at 3 dose levels) compared to PCV15 in infants at 2,...

Active, not recruiting
Pneumococcal Vaccines
Biological: 0.5 ml dose of 1.1 mcg VAX-24
Biological: 0.5 ml dose of 2.2 mcg VAX-24

Trial sponsors

Pfizer logo
BioNTech logo
Abbott logo
Amgen logo
B
Janssen (J&J Innovative Medicine) logo
M
Vaxcyte logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems